We speak science. It’s in our DNA.
With our biomedical research backgrounds and biotech communications experience, we translate the science and technology into the value story that matters for your stakeholders and business goals.
Jessica Yingling, Ph.D.
President and Founder
Jessica founded Little Dog Communications Inc. to work with companies and organizations that, through research, innovation and new technologies are helping develop tomorrow’s medicines and reimagining the future of healthcare.
Biotech and healthcare communications have an added layer of complexity due to the science. Jessica merges a biomedical research background with communications EQ to find the best way to convey new science and technologies to motivate audiences and stakeholders.
Before founding Little Dog Communications in 2011, Jessica was director of corporate communications at Fate Therapeutics, where she built and successfully executed a complete corporate communications program that established Fate as a pioneering company in stem cell medicines. This program led to numerous company awards and recognitions, including being named one of the most innovative biotechs by Fast Company.
Previous to Fate, Jessica was at Porter Novelli Life Sciences, where she gained experience working with a wide range of accounts from start-up biotechs translating early stage technology to public life sciences companies with marketed products.
Jessica achieved her Ph.D. in biomedical sciences from University of California, San Diego, where she was awarded a National Science Foundation pre-doctoral fellowship. She is author in multiple top-tier review articles and research papers, including Cell. She earned a B.S. with honors in biochemistry and art history from the University of Arizona, where she received a number of academic and research scholarships and awards.
Peggy Vorwald, Ph.D.
Prior to joining Little Dog Communications, Peggy worked as a medical writer for INC Research where she created presentations for health care professionals that clearly and accurately reported results from clinical trials. She earned her Ph.D. in biological chemistry from University of California, Los Angeles, where she worked in the laboratory of Eddy De Robertis M.D., Ph.D., where she investigated the mechanism of the Wnt signaling pathway and its role in embryo development. During her graduate school experience Peggy was elected Biological Chemistry Department Student President for three years, sat on the David Geffen School of Medicine Strategic Planning Committee and LCME Accreditation Task Force as the graduate student representative, and volunteered as a tutor for the non/profit organization, School on Wheels. She has also earned a certificate in project management and actively volunteers at the Reuben H. Fleet Science Center, where she helps to ignite a passion for science in the San Diego community.